E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
What is sarcopenic obesity, and why should Indians look beyond BMI and prioritise muscle health? Dr Chirantan Bose and Dr Preetesh Bhandari, co-founders of VytalYou, explain…
dineshwori
A cardiac event may appear sudden, but the underlying risk can develop over years. Appropriate tests can help identify cardiovascular risk early, even among people who consider themselves fit and healthy.
imphoenix82
Cardiovascular risk can develop early and often without obvious symptoms. Doctors highlight the health checks young adults should consider to detect potential heart risks early.
imphoenix82
Dr. N.K. Soni brings more than four decades of experience in Internal Medicine to strengthen the management of complex and chronic medical conditions at Yashoda Medicity.
imphoenix82
Under the rebrand, ‘Novo’ will be used as the company’s day-to-day name, while Novo Nordisk A/S will remain its legal global company name.
imphoenix82
Researchers suggest that microbiome-based therapies should be tailored to regional populations rather than adopting approaches developed solely from Western populations.
imphoenix82
FiberSense advances toward commercialisation following CE Approval of
Continuous Glucose Monitoring System.
imphoenix82
Novo Nordisk plans to begin a phase 3 development programme for zenagamtide in adults with type 2 diabetes during the second half of 2026.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
